Melanotan I
Afamelanotide / Scenesse
FDA-approved 2019 (Scenesse) for a rare sun-sensitivity disorder — the clinically validated melanocortin agonist, but not for tanning.
Verdict — C · Emerging / Mixed
A real FDA approval for a narrow rare disease, with phase-3 evidence. The gray-market tanning use is unapproved and carries a milder but similar melanocytic concern to MT-II. The clinical pathway (EPP) is well-validated; the recreational pathway is not. Gray-market supply is extremely limited.
Overview
Melanotan I (afamelanotide, Scenesse) is a linear alpha-MSH analogue FDA-approved in 2019 for erythropoietic protoporphyria (EPP), a rare disorder causing severe pain upon sun exposure. Unlike Melanotan II it lacks the potent sexual/erectile activity but still stimulates eumelanin production. The approved indication has solid phase-3 RCT support; the gray-market tanning use case is a completely different and unapproved application. Sourcing outside an EPP prescription is essentially gray-market only.
PepScore Breakdown — the four axes
Evidence
35% weightHow strong is the published human science?
Sourcing & COA
30% weightOur moatCan a buyer obtain an independently-verified, high-purity version? — our proprietary layer.
Safety & Risk
25% weightWhat is the real-world harm potential?
Practicality
10% weightHow easy is it to actually run a verified version?
Sources & Citations
Every claim cites a primary source. Citations are machine-audited against NCBI — see methodology.
Want a clinical path?
Talk to a licensed provider about Melanotan I and whether it's appropriate for your situation.
Talk to a Provider ↗Telehealth. Not medical advice — for educational purposes.
Get the PepEvolution Dispatch
Monthly COA findings, vendor changes, and new grades. Research/educational only — no spam.
Free. Unsubscribe anytime. Research/educational content only.
Educational only — not medical advice. PepScore is an educational research grade, not a prescription or dosing recommendation. Some vendor links are affiliate links — this never affects grades. Consult a licensed healthcare provider before using any compound.